GENinCode Predictive Genetics

📍 Oxford, United Kingdom🗓 Founded 2018👥 33 employees💰 Last funded Sep 2019
Biotechnology Research🌐 genincode.com
Website LinkedIn
GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification including coronary artery disease such as angina and myocardial infarction often referred to as heart attack. CVD also includes stroke, heart failure, hypertension and other vascular heart diseases and is the leading cause of death and disability worldwide accounting for 1 in every 4 deaths in the United States. GENinCode provides advanced genomic technology, products and recommendations fully validated by our scientific and clinical team. Our goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patient’s genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. Our technology helps select the optimal treatment pathway and informs and educates patients to become more aware of their cardiovascular risk helping patient adherence and empowerment to better manage their health. GENinCode technology and advanced genomic products provide information that helps patients and healthcare practitioners to assess and predict the onset of cardiovascular disease, thrombosis, and the diagnosis of Familial Hypercholesterolemia. Our online reporting system SITAB® helps inform doctors of their patients’ health risk enabling patient behavioral and lifestyle changes alongside delivering the most effective therapies and treatment pathways.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in GENinCode Predictive Genetics?
GENinCode Predictive Genetics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did GENinCode Predictive Genetics last raise funding?
The most recent investment in GENinCode Predictive Genetics recorded on gritt.io was in September 2019.
When was GENinCode Predictive Genetics founded?
GENinCode Predictive Genetics was founded in 2018.
What industry is GENinCode Predictive Genetics in?
GENinCode Predictive Genetics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GENinCode Predictive Genetics based?
GENinCode Predictive Genetics is headquartered in Oxford, United Kingdom.